Grahame Healthcare Ltd NI682335 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Dispensing Chemist Digita Accounts Production Advanced 6.30.9574.0 true NI682335 2023-04-01 2024-03-31 NI682335 2024-03-31 NI682335 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-03-31 NI682335 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 NI682335 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 NI682335 bus:SmallEntities 2023-04-01 2024-03-31 NI682335 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 NI682335 bus:FilletedAccounts 2023-04-01 2024-03-31 NI682335 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 NI682335 bus:RegisteredOffice 2023-04-01 2024-03-31 NI682335 bus:Director1 2023-04-01 2024-03-31 NI682335 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-04-01 2024-03-31 NI682335 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 NI682335 bus:Agent1 2023-04-01 2024-03-31 NI682335 countries:NorthernIreland 2023-04-01 2024-03-31 NI682335 2023-03-31 NI682335 2022-04-01 2023-03-31 NI682335 2023-03-31 NI682335 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-03-31 NI682335 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 NI682335 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: NI682335

Grahame Healthcare Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Grahame Healthcare Ltd

Contents

Company Information

1

Accountants' Report

2

Abridged Balance Sheet

3 to 4

Notes to the Unaudited Abridged Financial Statements

5 to 7

 

Grahame Healthcare Ltd

Company Information

Director

Mr Richard Brian Grahame

Registered office

154 Portaferry Road
Newtownards
Co Down
BT22 2AJ

Accountants

Hamilton Morris Waugh
Chartered Certified Accountants
34 Dufferin Avenue
Bangor
Down
BT20 3AA

 

Chartered Certified Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Grahame Healthcare Ltd
for the Year Ended 31 March 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Grahame Healthcare Ltd for the year ended 31 March 2024 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants (ACCA), we are subject to its ethical and other professional requirements.

This report is made solely to the Board of Directors of Grahame Healthcare Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Grahame Healthcare Ltd and state those matters that we have agreed to state to the Board of Directors of Grahame Healthcare Ltd, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Grahame Healthcare Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Grahame Healthcare Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Grahame Healthcare Ltd. You consider that Grahame Healthcare Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Grahame Healthcare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Hamilton Morris Waugh
Chartered Certified Accountants
34 Dufferin Avenue
Bangor
Down
BT20 3AA

30 August 2024

 

Grahame Healthcare Ltd

(Registration number: NI682335)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Investment property

100,000

100,000

Investments

938,439

938,439

 

1,038,439

1,038,439

Current assets

 

Cash at bank and in hand

 

48

36

Creditors: Amounts falling due within one year

(798,248)

(275,836)

Net current liabilities

 

(798,200)

(275,800)

Total assets less current liabilities

 

240,239

762,639

Creditors: Amounts falling due after more than one year

(282,065)

(782,089)

Accruals and deferred income

 

(570)

(528)

Net liabilities

 

(42,396)

(19,978)

Capital and reserves

 

Called up share capital

5

100

100

Retained earnings

(42,496)

(20,078)

Shareholders' deficit

 

(42,396)

(19,978)

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Grahame Healthcare Ltd

(Registration number: NI682335)
Abridged Balance Sheet as at 31 March 2024

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 30 August 2024
 

.........................................
Mr Richard Brian Grahame
Director

 

Grahame Healthcare Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in Northern Ireland.

The address of its registered office is:
154 Portaferry Road
Newtownards
Co Down
BT22 2AJ

These financial statements were authorised for issue by the director on 30 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

 

Grahame Healthcare Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2023 - 0).

 

Grahame Healthcare Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Cost or valuation

Depreciation

Carrying amount

At 31 March 2024

Investment properties

2024
£

At 1 April

100,000

There has been no valuation of investment property by an independent valuer.

5

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary Shares of £1 each

100

100

100

100